Abstract
Chlamydia trachomatis is the most frequently detected agent of sexually transmitted infections worldwide. Infection of the lower female genital tract (FGT) can cause cervicitis and if ascending to the upper FGT may result in serious sequelae such as pelvic inflammatory disease (PID), salpingitis and tubal factor infertility (TFI). The factors leading to this complication are still not completely understood. We elaborate four different models for host–pathogen interactions in C. trachomatis infections that may promote disease development: (1) acute infection, (2) repeated infections, (3) chronic/persistent infections and (4) non-inflammatory colonization. Whereas experimental data exist for all of these models in vitro, ex vivo and in vivo, we were interested in seeing what clinical evidence we have supporting one or the other model. We particularly focused on data that favour the one or the other model for TFI development in C. trachomatis infection and speculate on future studies that could integrate in vitro findings for a better characterization of the situation in vivo.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BV:
-
Bacterial vaginosis
- DFO:
-
Deferoxamine
- EB:
-
Elementary body
- EP:
-
Ectopic pregnancy
- FGT:
-
Female genital tract
- HSP60:
-
Heat-shock protein 60
- IFN-γ:
-
Interferon-γ
- OmpA:
-
Outer membrane protein A
- PID:
-
Pelvic inflammatory disease
- RB:
-
Reticulate body
- TFI:
-
Tubal factor infertility
References
Aghaizu A, Reid F, Kerry S, Hay PE, Mallinson H, Jensen JS, Kerry S, Kerry S, Oakeshott P (2014) Frequency and risk factors for incident and redetected Chlamydia trachomatis infection in sexually active, young, multi-ethnic women: a community based cohort study. Sex Transm Infect. 90(7):524–528
Al-Younes HM, Rudel T, Meyer TF (1999) Characterization and intracellular trafficking pattern of vacuoles containing Chlamydia pneumoniae in human epithelial cells. Cell Microbiol 1(3):237–247
Al-Younes HM, Rudel T, Brinkmann V, Szczepek AJ, Meyer TF (2001) Low iron availability modulates the course of Chlamydia pneumoniae infection. Cell Microbiol 3(6):427–437
Bahar-Shany K, Brand H, Sapoznik S, Jacob-Hirsch J, Yung Y, Korach J, Perri T, Cohen Y, Hourvitz A, Levanon K (2014) Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma. Gynecol Oncol 132(2):322–327
Bakken IJ, Skjeldestad FE, Nordbø SA (2007) Chlamydia trachomatis infections increase the risk for ectopic pregnancy: a population-based, nested case-control study. Sex Transm Dis 34(3):166–169
Batteiger BE, Tu W, Ofner S, Van Der Pol B, Stothard DR, Orr DP, Katz BP, Fortenberry JD (2010) Repeated Chlamydia trachomatis genital infections in adolescent women. J Infect Dis 201(1):42–51
Bavoil PM (2014) What’s in a word: the use, misuse, and abuse of the word “persistence” in Chlamydia biology. Front Cell Infect Microbiol 4:27
Beatty WL, Morrison RP, Byrne GI (1994) Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 58(4):686–699
Belland RJ, Nelson DE, Virok D, Crane DD, Hogan D, Sturdevant D, Beatty WL, Caldwell HD (2003) Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation. Proc Natl Acad Sci USA. 100(26):15971–15976
Bragina EY, Gomberg MA, Dmitriev GA (2001) Electron microscopic evidence of persistent chlamydial infection following treatment. J Eur Acad Dermatol Venereol 15(5):405–409
Byrne GI, Lehmann LK, Landry GJ (1986) Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun 53(2):347–351
Caldwell HD, Wood H, Crane D et al (2003) Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Invest. 111(11):1757–1769
Carey AJ, Beagley KW (2010) Chlamydia trachomatis, a hidden epidemic: effects on female reproduction and options for treatment. Am J Reprod Immunol 63(6):576–586
Carey AJ, Huston WM, Cunningham KA, Hafner LM, Timms P, Beagley KW (2013) Characterization of in vitro Chlamydia muridarum persistence and utilization in an in vivo mouse model of Chlamydia vaccine. Am J Reprod Immunol 69(5):475–485
Clark RB, Schatzki PF, Dalton HP (1982) Ultrastructural analysis of the effects of erythromycin on the morphology and developmental cycle of Chlamydia trachomatis HAR-13. Arch Microbiol 133(4):278–282
Craig AP, Kong FY, Yeruva L, Hocking JS, Rank RG, Wilson DP, Donovan B (2015) Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women? Modelling the impact of autoinoculation from the gastrointestinal tract to the genital tract. BMC Infect Dis 15:200
De Clercq E, Kalmar I, Vanrompay D (2013) Animal models for studying female genital tract infection with Chlamydia trachomatis. Infect Immun 81(9):3060–3067
Dean D, Suchland RJ, Stamm WE (2000) Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis 182(3):909–916
Deka S, Vanover J, Dessus-Babus S, Whittimore J, Howett MK, Wyrick PB, Schoborg RV (2006) Chlamydia trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells. Cell Microbiol 8(1):149–162
Deka S, Vanover J, Sun J, Kintner J, Whittimore J, Schoborg RV (2007) An early event in the herpes simplex virus type-2 replication cycle is sufficient to induce Chlamydia trachomatis persistence. Cell Microbiol 9(3):725–737
Dill BD, Dessus-Babus S, Raulston JE (2009) Identification of iron-responsive proteins expressed by Chlamydia trachomatis reticulate bodies during intracellular growth. Microbiology 155(Pt 1):210–219
Dreses-Werringloer U, Padubrin I, Jürgens-Saathoff B, Hudson AP, Zeidler H, Köhler L (2000) Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob Agents Chemother 44(12):3288–3297
Frazer LC, O’Connell CM, Andrews CW Jr, Zurenski MA, Darville T (2011) Enhanced neutrophil longevity and recruitment contribute to the severity of oviduct pathology during Chlamydia muridarum infection. Infect Immun 79(10):4029–4041
Geisler WM (2015) Diagnosis and management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: summary of evidence reviewed for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis 61(Suppl 8):S774–S784
Geisler WM, Lensing SY, Press CG, Hook EW 3rd (2013) Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection. J Infect Dis 207(12):1850–1856
Geisler WM, Uniyal A, Lee JY, Lensing SY, Johnson S, Perry RC, Kadrnka CM, Kerndt PR (2015) Azithromycin versus doxycycline for urogenital Chlamydia trachomatis infection. N Engl J Med 373(26):2512–2521
Gieffers J, Rupp J, Gebert A, Solbach W, Klinger M (2004) First-choice antibiotics at subinhibitory concentrations induce persistence of Chlamydia pneumoniae. Antimicrob Agents Chemother 48(4):1402–1405
Golden MR, Whittington WL, Handsfield HH et al (2005) Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 352(7):676–685
Gratrix J, Singh AE, Bergman J, Egan C, Plitt SS, McGinnis J, Bell CA, Drews SJ, Read R (2015) Evidence for increased Chlamydia case finding after the introduction of rectal screening among women attending 2 Canadian sexually transmitted infection clinics. Clin Infect Dis 60(3):398–404
Hall JV, Sun J, Slade J, Kintner J, Bambino M, Whittimore J, Schoborg RV (2014) Host nectin-1 is required for efficient Chlamydia trachomatis serovar E development. Front Cell Infect Microbiol. 4:158
Harper A, Pogson CI, Jones ML, Pearce JH (2000) Chlamydial development is adversely affected by minor changes in amino acid supply, blood plasma amino acid levels, and glucose deprivation. Infect Immun 68(3):1457–1464
Hillis SD, Owens LM, Marchbanks PA, Amsterdam LF, Mac Kenzie WR (1997) Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 176(1 Pt 1):103–107
Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P (2004) Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 72(4):1843–1855
Hosenfeld CB, Workowski KA, Berman S, Zaidi A, Dyson J, Mosure D, Bolan G, Bauer HM (2009) Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis 36(8):478–489
Igietseme JU, Portis JL, Perry LL (2001) Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae. Infect Immun 69(3):1832–1840
Jerchel S, Knebel G, König P, Bohlmann MK, Rupp J (2012) A human fallopian tube model for investigation of C. trachomatis infections. J Vis Exp 66:4036
Johnson FW, Hobson D (1977) The effect of penicillin on genital strains of Chlamydia trachomatis in tissue culture. J Antimicrob Chemother 3(1):49–56
Kahane S, Friedman MG (1992) Reversibility of heat shock in Chlamydia trachomatis. FEMS Microbiol Lett 76(1–2):25–30
Kavanagh K, Wallace LA, Robertson C, Wilson P, Scoular A (2013) Estimation of the risk of tubal factor infertility associated with genital chlamydial infection in women: a statistical modelling study. Int J Epidemiol 42(2):493–503
Kelver ME et al. (1996) Estrogen regulation of lactoferrin expression in human endometrium. Am J Reprod Immunol 36(5):243–247
Kessler M, Zielecki J, Thieck O, Mollenkopf HJ, Fotopoulou C, Meyer TF (2012) Chlamydia trachomatis disturbs epithelial tissue homeostasis in fallopian tubes via paracrine Wnt signaling. Am J Pathol 180(1):186–198
Kintner J, Lajoie D, Hall J, Whittimore J, Schoborg RV (2014) Commonly prescribed β-lactam antibiotics induce C. trachomatis persistence/stress in culture at physiologically relevant concentrations. Front Cell Infect Microbiol 4:44
Klöckner A, Otten C, Derouaux A et al (2014) AmiA is a penicillin target enzyme with dual activity in the intracellular pathogen Chlamydia pneumoniae. Nat Commun 5:4201
Kramer MJ, Gordon FB (1971) Ultrastructural analysis of the effects of penicillin and chlortetracycline on the development of a genital tract Chlamydia. Infect Immun 3(2):333–341
Land JA, Van Bergen JE, Morré SA, Postma MJ (2010) Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Hum Reprod Update 16(2):189–204
Levanon K, Ng V, Piao HY et al (2010) Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis. Oncogene 29(8):1103–1113
Lewis ME, Belland RJ, AbdelRahman YM et al (2014) Morphologic and molecular evaluation of Chlamydia trachomatis growth in human endocervix reveals distinct growth patterns. Front Cell Infect Microbiol. 4:71
Liechty ER, Bergin IL, Bassis CM, Chai D, LeBar W, Young VB, Bell JD (2015) The levonorgestrel-releasing intrauterine system is associated with delayed endocervical clearance of Chlamydia trachomatis without alterations in vaginal microbiota. Pathog Dis 73(8):ftv070
Low N, Egger M, Sterne JA, Harbord RM, Ibrahim F, Lindblom B, Herrmann B (2006) Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women’s Cohort Study. Sex Transm Infect. 2(3):212–218
Macleod J, Salisbury C, Low N et al (2005) Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study. BMJ 330(7497):940
Marks E, Tam MA, Lycke NY (2010) The female lower genital tract is a privileged compartment with IL-10 producing dendritic cells and poor Th1 immunity following Chlamydia trachomatis infection. PLoS Pathog 6(11):e1001179
Marrazzo JM, White CL, Krekeler B, Celum CL, Lafferty WE, Stamm WE, Handsfield HH (1997) Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med 127(9):796–803
Matsumoto A, Manire GP (1970) Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci. J Bacteriol 101(1):278–285
Menon S, Timms P, Allan JA, Alexander K, Rombauts L, Horner P, Keltz M, Hocking J, Huston WM (2015) Human and pathogen factors associated with Chlamydia trachomatis-related infertility in women. Clin Microbiol Rev 28(4):969–985
Morrison RP, Caldwell HD (2002) Immunity to murine chlamydial genital infection. Infect Immun 70(6):2741–2751
Morrison RP, Belland RJ, Lyng K, Caldwell HD (1989) Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med 170(4):1271–1283
Newman L, Rowley J, Vander Hoorn S et al (2015) Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS ONE 10(12):e0143304
Paavonen J, Puolakkainen M, Paukku M, Sintonen H (1998) Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program. Obstet Gynecol 92(2):292–298
Patton DL, Askienazy-Elbhar M, Henry-Suchet J, Campbell LA, Cappuccio A, Tannous W, Wang SP, Kuo CC (1994) Detection of Chlamydia trachomatis in fallopian tube tissue in women with postinfectious tubal infertility. Am J Obstet Gynecol 171(1):95–101
Perfettini JL, Darville T, Dautry-Varsat A, Rank RG, Ojcius DM (2002) Inhibition of apoptosis by gamma interferon in cells and mice infected with Chlamydia muridarum (the mouse pneumonitis strain of Chlamydia trachomatis). Infect Immun 70(5):2559–2565
Perry LL, Su H, Feilzer K, Messer R, Hughes S, Whitmire W, Caldwell HD (1999) Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. J Immunol 162(6):3541–3548
Peters RP, Dubbink JH, van der Eem L (2014) Cross-sectional study of genital, rectal, and pharyngeal Chlamydia and gonorrhea in women in rural South Africa. Sex Transm Dis 41(9):564–569
Phillips Campbell R, Kintner J, Whittimore J, Schoborg RV (2012) Chlamydia muridarum enters a viable but non-infectious state in amoxicillin-treated BALB/c mice. Microbes Infect 14(13):1177–1185
Phillips DM, Swenson CE, Schachter J (1984) Ultrastructure of Chlamydia trachomatis infection of the mouse oviduct. J Ultrastruct Res 3:244–256
Phillips-Campbell R, Kintner J, Schoborg RV (2014) Induction of the Chlamydia muridarum stress/persistence response increases azithromycin treatment failure in a murine model of infection. Antimicrob Agents Chemother 58(3):1782–1784
Picard MD, Bodmer JL, Gierahn TM et al (2015) Resolution of Chlamydia trachomatis infection is associated with a distinct T-cell response profile. Clin Vaccine Immunol 22(11):1206–1218
Pospischil A, Borel N, Chowdhury EH, Guscetti F (2009) Aberrant chlamydial developmental forms in the gastrointestinal tract of pigs spontaneously and experimentally infected with Chlamydia suis. Vet Microbiol 135(1–2):147–156
Prusty Böhme L, Bergmann B, Siegl C, Krause E, Mehlitz A, Rudel T (2012) Imbalanced oxidative stress causes chlamydial persistence during non-productive human herpes virus co-infection. PLoS ONE 7(10):e47427
Ramsey KH, Miranpuri GS, Sigar IM, Ouellette S, Byrne GI (2001) Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome. Infect Immun 69(8):5131–5137
Rank RG, Yeruva L (2014) Hidden in plain sight: chlamydial gastrointestinal infection and its relevance to persistence in human genital infection. Infect Immun 82(4):1362–1371
Raulston JE (1997) Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins. Infect Immun 65(11):4539–4547
Raulston JE, Miller JD, Davis CH, Schell M, Baldwin A, Ferguson K, Lane H (2007) Identification of an iron-responsive protein that is antigenic in patients with Chlamydia trachomatis genital infections. FEMS Immunol Med Microbiol 51(3):569–576
Riley MM, Zurenski MA, Frazer LC, O’Connell CM, Andrews CW Jr, Mintus M, Darville T (2012) The recall response induced by genital challenge with Chlamydia muridarum protects the oviduct from pathology but not from reinfection. Infect Immun 80(6):2194–2203
Savy M, Hennig BJ, Doherty CP et al (2010) Haptoglobin and sickle cell polymorphisms and risk of active trachoma in Gambian children. PLoS ONE 5(6):e11075
Scott Lamontagne D, Baster K, Emmett L et al (2007) Incidence and reinfection rates of genital chlamydial infection among women aged 16-24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group. Sex Transm Infect. 83(4):292–303
Shemer Y, Sarov I (1985) Inhibition of growth of Chlamydia trachomatis by human gamma interferon. Infect Immun 48(2):592–596
Slade J, Hall JV, Kintner J, Schoborg RV (2016) Chlamydial pre-infection protects from subsequent herpes simplex virus-2 challenge in a murine vaginal super-infection model. PLoS ONE 11(1):e0146186
Stephens RS (2003) The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 11(1):44–51
Tan C, Hsia RC, Shou H, Carrasco JA, Rank RG, Bavoil PM (2010) Variable expression of surface-exposed polymorphic membrane proteins in in vitro-grown Chlamydia trachomatis. Cell Microbiol 12(2):174–187
Tanami Y, Yamada Y (1973) Miniature cell formation in Chlamydia psittaci. J Bacteriol 114(1):408–412
Thompson CC, Carabeo RA (2011) An optimal method of iron starvation of the obligate intracellular pathogen, Chlamydia trachomatis. Front Microbiol 2:20
Torrone E, Papp J, Weinstock H, Centers for Disease Control and Prevention (CDC) (2014) Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years–United States, 2007-2012. MMWR Morb Mortal Wkly Rep 63(38):834–838
Trebach JD, Chaulk CP, Page KR, Tuddenham S, Ghanem KG (2015) Neisseria gonorrhoeae and Chlamydia trachomatis among women reporting extragenital exposures. Sex Transm Dis 42(5):233–239
van Liere GA, Hoebe CJ, Wolffs PF, Dukers-Muijrers NH (2014) High co-occurrence of anorectal chlamydia with urogenital chlamydia in women visiting an STI clinic revealed by routine universal testing in an observational study; a recommendation towards a better anorectal chlamydia control in women. BMC Infect Dis 14:274
van Valkengoed IG, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ (2004) Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes—implications for cost-effectiveness analyses. Int J Epidemiol 33(2):416–425
Vanover J, Sun J, Deka S, Kintner J, Duffourc MM, Schoborg RV (2008) Herpes simplex virus co-infection-induced Chlamydia trachomatis persistence is not mediated by any known persistence inducer or anti-chlamydial pathway. Microbiology 154(Pt 3):971–978
Vanover J, Kintner J, Whittimore J, Schoborg RV (2010) Interaction of herpes simplex virus type 2 (HSV-2) glycoprotein D with the host cell surface is sufficient to induce Chlamydia trachomatis persistence. Microbiology 156(Pt 5):1294–1302
Vardhan H, Bhengraj AR, Jha R, Singh Mittal A (2009) Chlamydia trachomatis alters iron-regulatory protein-1 binding capacity and modulates cellular iron homeostasis in HeLa-229 cells. J Biomed Biotechnol. 2009:342032
Versteeg B, van Rooijen MS, Schim van der Loeff MF, de Vries HJ, Bruisten SM (2014) No indication for tissue tropism in urogenital and anorectal Chlamydia trachomatis infections using high-resolution multilocus sequence typing. BMC Infect Dis 14:464
Walker J, Tabrizi SN, Fairley CK et al (2012) Chlamydia trachomatis incidence and re-infection among young women—behavioural and microbiological characteristics. PLoS One 7(5):e37778
Wallace LA, Scoular A, Hart G, Reid M, Wilson P, Goldberg DJ (2008) What is the excess risk of infertility in women after genital chlamydia infection? A systematic review of the evidence. Sex Transm Infect. 84(3):171–175
Wolf K, Fischer E, Hackstadt T (2000) Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells. Infect Immun 68(4):2379–2385
Wyrick PB (2000) Intracellular survival by Chlamydia. Cell Microbiol 2(4):275–282
Wyrick PB (2010) Chlamydia trachomatis persistence in vitro: an overview. J Infect Dis 201(Suppl 2):S88–S95
Wyrick PB, Knight ST (2004) Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin. J Antimicrob Chemother 54(1):79–85
Xu F, Stoner BP, Taylor SN, Mena L, Tian LH, Papp J, Hutchins K, Martin DH, Markowitz LE (2011) Use of home-obtained vaginal swabs to facilitate rescreening for Chlamydia trachomatis infections: two randomized controlled trials. Obstet Gynecol 118(2 Pt 1):231–239
Yeruva L, Spencer N, Bowlin AK, Wang Y, Rank RG (2013a) Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection. Pathog Dis 68(3):88–95
Yeruva L, Melnyk S, Spencer N, Bowlin A, Rank RG (2013b) Differential susceptibilities to azithromycin treatment of chlamydial infection in the gastrointestinal tract and cervix. Antimicrob Agents Chemother 57(12):6290–6294
Yoshimura K, Yoshimura M, Kobayashi T, Kubo T, Hachisuga T, Kashimura M (2009) Can bacterial vaginosis help to find sexually transmitted diseases, especially chlamydial cervicitis? Int J STD AIDS 20(2):108–111
Zhang Q, Huang Y, Gong S, Yang Z, Sun X, Schenken R, Zhong G (2015) In vivo and ex vivo imaging reveals a long-lasting chlamydial infection in the mouse gastrointestinal tract following genital tract inoculation. Infect Immun 83(9):3568–3577
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Schuchardt, L., Rupp, J. (2016). Chlamydia trachomatis as the Cause of Infectious Infertility: Acute, Repetitive or Persistent Long-Term Infection?. In: Häcker, G. (eds) Biology of Chlamydia . Current Topics in Microbiology and Immunology, vol 412. Springer, Cham. https://doi.org/10.1007/82_2016_15
Download citation
DOI: https://doi.org/10.1007/82_2016_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-71230-7
Online ISBN: 978-3-319-71232-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)